MedPath

Convalescent Plasma therapy for COVID-19 Patients

Not Applicable
Recruiting
Conditions
COVID-19 Disease.
COVID-19 Disease
U07.02
Registration Number
IRCT20200325046860N1
Lead Sponsor
Darmanara .Co
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

COVID-19 infected patients with moderate to severe symptoms
COVID-19 infected patients with severe symptoms non responding to other treatments

Exclusion Criteria

NO confirmed COVID-19 Disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improving Respiratory function of patients. Timepoint: Every 24 hours. Method of measurement: Clinical and, Para-clinical.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath